Skip to main content
. 2024 Jun 24;12(6):101934. doi: 10.1016/j.jvsv.2024.101934

Fig 5.

Fig 5

(A) Analysis of Short Form Health Survey 36 (SF-36) of patients with upper limb lymphedema (ULL) revealed improvements in a broad range of complaints, reaching significance for physical functioning (66.0 ± 26.9 vs 89.0 ± 8.9; P = .02) and health change (37.5 ± 21.3 vs 85 ± 22.4; P = .01) 12 months postoperatively. (B) The LYMPH Q showed significant improvements of symptoms (44.3 ± 19.1 vs 66.8 ± 2.7; P = .02), function (50.1 ± 17.8 vs 77.4 ± 13.6; P = .04), and psychological well-being (44.7 ± 16.2 vs 74.2 ± 15.0; P = .04) at 12 months postoperatively.